Haemophilus influenzae type B (HiB) VACCINE

Ten lots of PedvaxHIB and two lots of COMVAX are being voluntarily recalled by Merck and Co due to concerns about product sterility.  The recall involves approximately 1 million doses of vaccine.  The risk of vaccine contamination is reportedly theoretical; no vaccines have been found to be contaminated and there have been no reports of illness or injury.  (Dec 07) The FDA has listed the specific lots that are being recalled at: www.fda.gov/cber/recalls/merckhib121107.htm CDC Q&A regarding the recall: http://www.cdc.gov/vaccines/recs/recalls/hib-recall-faqs-12-12-07.htm Merck's National Service Center that can answer questions about medical and other issues related to this recall: 1-800-672-6372 Letter from Merck with more information: http://www.cdc.gov/vaccines/vac-gen/shortages/downloads/hib-recall-12-12-07.doc

This page was last updated on January 23, 2008 © 2007 Institute for Vaccine Safety